SCHEMBL7666295

SCHEMBL7666295

NC(=O)c1ccc(C(c2c[nH]cn2)C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 1/20 0.38
CYP2C19 P33261 2/20 0.38
HSD17B10 Q99714 2/20 0.38
POLB P06746 1/20 0.38
CYP3A4 P08684 1/20 0.38
PARP1 P09874 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KIF11 P52732 1/20 0.36
PARP10 Q53GL7 4/20 0.35
PLA2G10 O15496 1/20 0.35
PLA2G2A P14555 1/20 0.35
MKNK1 Q9BUB5 2/20 0.34
MKNK2 Q9HBH9 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663652 0.84
SCHEMBL7675183 0.81 KIF11 (0.35) KIF11
SCHEMBL7668534 0.79 ALDH1A1 (0.34) ALDH1A1
SCHEMBL5891827 0.78 CYP19A1 (0.36) OPRD1TSHRKIF11PHGDH
SCHEMBL6775340 0.75 BRS3 (0.33) ALDH1A1
SCHEMBL8149150 0.72 NR3C1 (0.35) SMN1; SMN2KDM4EALDH1A1LMNAHPGD
SCHEMBL7664213 0.72 KIF11 (0.36) KIF11
SCHEMBL971959 0.72 CA2 (0.36) OPRD1CYP2C19HSD17B10POLBCYP3A4
SCHEMBL28813721 0.71
SCHEMBL6781368 0.71 AXL (0.39) GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407132-B1 ANTIHISTAMINES, ANTIALLERGENS, ANTIASTHMATICS, ANTICONVULSANTS, AND ANTIDEPRESSANTS; SKIN RASH TREATMENT JAMES BLACK FOUNDATION LIMITED (GB) 2002-06-18 US disclosed
WO-1999005115-A1 SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE AS HISTAMINE H3 RECEPTOR LIGANDS JAMES BLACK FOUNDATION LIMITED (GB) 1999-02-04 WO disclosed